| [1］ Nugent AW，Daubeney PE，Chondros P. The epidemiology of childhood cardiomyopathy in Australia［J］. N Engl J Med， 2003， 348:1639-1646. [2］ Lipshultz SE， Sleeper LA， Towbin JA. The incidence of pediatric cardiomyopathy in two regions of the United States［J］. N Engl J Med， 2003， 348: 1647-1655. [3］ Elliott P，Andersson B，Arbustini E. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases［J］. Eur Heart J， 2008， 29:270-276. [4］ Maron BJ， Towbin JA， Thiene G. Contemporary definitions and classification of the cardiomyopathies［J］. Circulation， 2006， 113（14）: 1807-1816. [5］ 王虎， 惠汝太. 基因突变与扩张型心肌病［J］. 中华心血管病杂志， 2006， 34（3）:193-195. [6］ Kirchmann C，Kececioglu D，Korinthenberg R.Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies［J］. Pediatr Cardiol， 2005， 26（1）:66-72. [7］ Debray FG，Lambert M，Chevalier I. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases［J］. Pediatrics， 2007， 119（4）:722-733. [8］ Clarke SL，Bowron A，Gonzalez IL. Barth syndrome［J］. Orphanet J Rare Dis， 2013， 8:23. [9］ Colan SD，Lipshultz SE，Lowe AM. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry［J］. Circulation， 2007， 115（6）:773-781. [10］ Alcalai R， Seidman JG， Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics［J］. J Cardiovasc Electrophysiol， 2008，19（1）:104-110. [11］ McKenna WJ，Thiene G，Nava A. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology［J］. Br Heart J， 1994， 71:215-218. [12］ Yano M，Yamamoto T，Ikeda Y. Mechanisms of disease: ryanodine receptor defects in heart failure and fatal arrhythmia［J］. Nat Clin Pract Cardiovasc Med， 2006， 3:43-52. [13］ Radha J， Chanab A， Elkayamc U. Left ventricular noncompaction［J］. Prog in Cardiovasc Dis， 2010， 52:264-273. [14］ Chen R， Tsuji T， Ichida F. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction［J］. Mol Genet Metab， 2002， 77: 319-325. [15］ Jenni R，Oechslin EN， van der Loo B. Isolated ventricular noncompaction of the myocardium in adults［J］. Heart， 2007， 93:11-15. [16］ 时惠平，于梅艳. 心肌疾病的磁共振成像诊断［J］. 中华临床医师杂志， 2011， 5（23）:6871-6875. [17］ Ackerman MJ， Priori SG， Willems S. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society （HRS） and the European Heart Rhythm Association （EHRA） ［J］.Heart Rhythm， 2011， （8）:1308-1339. [18］ 洪葵， 胡金柱. 国际《遗传性心脏离子通道病与心肌病基因检测专家共识》中心肌病基因检测介绍［J］. 临床心血管病杂志，2012，28（5）:323-327. |
